PATENT CLAIM ANALYSIS

Application Number: 16385062
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "207100"]

Abstract:
Methods for inducing an immune response against Human Immunodeficiency Virus (HIV) in HIV-infected subjects undergoing antiretroviral therapy (ART) are described. The methods include administering an adenovirus vector primer vaccine and a modified vaccinia virus (MVA) vector booster vaccine encoding mosaic HIV antigens.

Claim (Index 5):
The method according to  claim 4 , wherein the first and second MVA vectors are administered at a total dose of about 1\u00d710 8  plaque forming units (pfu).

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.21951
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15693650', '15968834', '14863808', '15380123', '14632433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7374217987305806
- 35 USC 102 Novelty (BERT): 0.6309158451555872
- Combined Prediction Score: 0.7267712033730812
- Mean Citation Score: 488.40392
- Max Citation Score: 690.0668
- Similarity Product: 500.4436395407676

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test